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Available online 27 February 2016Oral transmission of Trypanosoma cruzi is a frequent cause of acute Chagas disease (ChD). In
the present cross-sectional study, we report the epidemiological, clinical, serological and
molecular outcomes of the second largest outbreak of oral ChD described in the literature. It
occurred in March 2009 in Chichiriviche de la Costa, a rural seashore community at the central
littoral in Venezuela. The vehicle was an artisanal guava juice prepared at the local school and
Panstrongylus geniculatus was the vector involved. TcI genotype was isolated from patients and
vector; some showed a mixture of haplotypes. Using molecular markers, parasitic loads were
high. Eighty-nine cases were diagnosed, the majority (87.5%) in school children 6–15 years
of age. Frequency of symptomatic patients was high (89.9%) with long-standing fever in
87.5%; 82.3% had pericardial effusion detected by echocardiogram and 41% had EKG abnormal-
ities. Three children, a pregnant woman and her stillborn child died (5.6% mortality). The
community was addressed by simultaneous determination of speciﬁc IgG and IgM, conﬁrmed
with indirect hemagglutination and lytic antibodies. Determination of IgG and IgA in saliva
had low sensitivity. No individual parasitological or serological technique diagnosed 100% of
cases. Culture and PCR detected T. cruzi in 95.5% of examined individuals. Based on the increas-
ing incidence of oral acute cases of ChD, it appears that food is becoming one of the most
important modes of transmission in the Amazon, Caribbean and Andes regions of America.
© 2016 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.
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Oral transmission of Trypanosoma cruzi has become the most frequent cause of acute cases of Chagas disease (ChD) in Brazil
(Pinto et al., 2008; Shikanai-Yasuda & Carvalho, 2012; Coura, 2015) and in Venezuela (Alarcón de Noya et al., 2015). Andrade
et al. (Andrade et al., 2014) registered 73 reports of acute ChD in Brazil during the past ten years contrasting with 41 cases
that were reported in the previous 20 years (1981–2001). In Venezuela, 249 cases were reported since 2007 (Alarcón de Noya
et al., 2015), and there were six new cases in 2015 alone, suggesting the progressive increase of oral outbreaks of ChD in the
Amazon, Caribbean and Andes regions (Alarcón de Noya & Noya, 2015).
The acute phase of ChD has been traditionally considered difﬁcult to diagnose due to the nonspeciﬁc clinical symptoms
(Bastos et al., 2010). However, when the outbreaks of orally transmitted ChD occur in families or schools, the discovery of a
case leads to the diagnosis of individuals at risk. The severe episode of the oral acute phase of ChD is the result of the host–path-
ogen interaction (Andrade et al., 2014; Cardillo et al., 2015) in which parasite inoculum, its genetic composition and the host's
immune response are involved. The reasons for which the symptoms are so severe and mortality so high in oral acute cases re-
mains unknown and the unexpected appearance of this medical emergency have limited the ability of the immunological studies
to explain these pathogenic mechanisms.
The ﬁrst large oral outbreak of ChD occurred in an urban school in a middle class area of Caracas, Venezuela in 2007. The out-
break resulted in an astonishing 103 infected individuals (Alarcón de Noya et al., 2010). Soon after, in March 2009, a second oc-
currence of fever and myocarditis arose, mainly in children, again in a school, from Chichiriviche de la Costa, a rural and touristic
seashore community located on the central Venezuelan coast (Alarcón de Noya & Martínez, 2009). The aim of the present work is
to report the epidemiological and clinic characteristics as well as the diagnostic procedures, the immunoglobulin isotype's re-
sponse in serum and saliva and the Trypanosoma cruzi molecular characterization of the second largest outbreak of ChD described
in the literature, highlighting the importance of this entity as a foodborne disease.Fig. 1. Geographical location of Chichiriviche de la Costa, Vargas State in Venezuela. A coastal place hidden in the mountains in the north central littoral of
Venezuela.
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2.1. Study population
It consisted of students, teachers and administrative personnel from a school located in Chichiriviche de la Costa. Fig. 1 shows
the location of the school (10°31′53.97″N 67°15′36.02″W), which belongs to Vargas state at the central-north littoral in
Venezuela, a small touristic town with a group of houses on the seashore and the town 1 km away, nestled in the mountain.
The simultaneous appearance of prolonged febrile syndrome in tens of children called the attention of the epidemiologist who
thought about the presence of acute oral ChD (OChD) based on a previous experience in the Venezuelan Municipality of Chacao
(Alarcón de Noya et al., 2010; Alarcón de Noya & Martínez, 2009). Once the ﬁrst 20 serum samples were diagnosed at the
“Instituto de Medicina Tropical (IMT), Universidad Central de Venezuela” in Caracas, the health authorities cordoned off the
area and sampled the entire population. The National Health Department organized a door-to-door investigation, interviewing
the population. Blood samples were sent to three Venezuelan reference centers, including the IMT.
2.2. Interview
Data was recorded from all infected persons and from a group of non-infected persons regarding their link to the school, their
ingestion of artisanal juices in the school, their knowledge of triatomines at home and their contact with them, the type and
duration of symptoms and whether or not they were hospitalized.
2.3. Clinical management
Patients were seen at various health centers and a speciﬁc protocol was not applied to everyone. In general, laboratory tests
were completed as well as electrocardiogram (EKG) and echosonography when necessary.
2.4. Laboratory diagnosis
A complete screening was done by taking one blood sample by venipuncture for serologic tests (IgM and IgG) to quickly iden-
tify the cases. From positive serological persons, a second blood sample was taken for culture and PCR as well as a saliva sample.
2.4.1. Immunoenzymatic assay
An in-house immunoenzymatic assay (ELISA) was performed with a T. cruzi epimastigotes delipidized antigen and processed
using Maxisorp plates (Díaz-Bello et al., 2008). ELISAs involving anti-human IgM and IgG alkaline phosphatase conjugates were
carried out simultaneously in all sera from individuals at risk. ELISA for saliva was achieved for the detection of speciﬁc IgG
and IgA antibodies, as well as for serum IgA.
2.4.2. Fresh and stained blood smears
Direct fresh and Giemsa thin smears were done from some blood samples.
2.4.3. Indirect hemagglutination (IHA)
Previously described methods were used in the IHA procedure (Jacobs & Lunde, 1957) in which the delipidized T. cruzi
epimastigotes antigen was adsorbed by fresh sheep red cells.
2.4.4. Lytic antibodies (LA)
They were performed with trypomastigotes from cellular cultures based on Krettli et al. methodology (Krettli, 2009). After
standardization in our laboratory, over 22% of lysis was considered a positive test.
2.4.5. Cultures
Aliquots of 2 mL blood samples collected by venipuncture in sodium citrate tubes were added to bacto agar blood base culture
medium and observed every 10 days. Once the cultures were found to be positive for epimastigotes, they were transferred to liver
infusion tryptose medium with 10% fetal bovine serum (Mourão & Mello, 1975).
2.4.6. Molecular studies
2.4.6.1. Polymerase chain reaction (PCR). 5 mL of patients' blood was mixed with an equal volume of 6 M guanidine HCl/0.2 mM
EDTA and processed according to Schijman et al. (Schijman et al., 2003). The PCR ampliﬁcations targeted a 330-bp fragment of
T. cruzi kinetoplastid minicircle DNA (Sturm et al., 1989).
2.4.6.2. Parasitic load. It was assessed by duplex real time PCR quantiﬁcation using Satellite DNA (SatDNA) qPCR and kinetoplastid
DNA (kDNA) qPCR assays as described (Duffy et al., 2013) and modiﬁed (Qvarnstrom et al., 2012). Standard curves were plotted
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per milliliter of blood (par. eq./mL).
2.4.6.3. Molecular typing of T. cruzi isolates.Genomic DNA from T. cruzi isolates was extracted and genotyped by PCR using three mo-
lecular targets: the intergenic region of the mini-exon gene (SL-IR gene), the D7 divergent domain of the 24Sa rRNAas (Souto
et al., 1996) and the size-variable domain of the 18S rRNA sequence (Clark & Pung, 1994). To detect the different TcI SL-IR geno-
types, the ampliﬁed products were excised from the gels, puriﬁed and cloned into a pGEM-T easy Vector (Promega, USA). Both
strands of at least three clones per sample were sequenced.
2.5. Case deﬁnition
A conﬁrmed case of ChD was any individual with parasites in their peripheral blood and all individuals with at least two
positive serologic tests based on different methods (WHO, 2002). Consequently, in this study, oral transmission cases included
all individuals related to the school, either with or without parasitemia, showing positive results in ELISA (IgG/IgM) and at
least one other positive conﬁrmatory test (IHA).
2.6. Statistical analysis
For this cross-sectional study, we used SPSS 19 for Windows (Version 19.0; Copyright SPSS Inc., 2010). In order to determine
whether there was an association between variables on study, clinical and epidemiological factors (except duration of fever) were
expressed as categorical variables and grouped in contingency tables to analyze prevalence, odds ratio (OR) with its respective
95% conﬁdence interval (95% CI), and the chi-square test (χ2). Continuous variables were analyzed by the t test for independent
samples. Statistical signiﬁcance was considered when p b 0.05.
2.7. Ethics
This study protocol was approved by the Scientiﬁc Ethic Committee of the “IMT, Universidad Central de Venezuela”. Each
patient or legal representative signed, after reading the term of free and informed consent, agreed the taking of samples and phys-
ical and other para-clinical exams.
3. Results
3.1. Demographic characteristics of the population
A serologic screening based on simultaneous determination of speciﬁc anti-T. cruzi IgG and IgM antibodies was achieved to 238
females (53.9%) and 203 males (46%). By that time, a 7 year old child had died with high fever and myocarditis. This case is taken
into account for the conﬁrmed cases and attack rate but does not count for the laboratory outcomes (Table 1). Of the 89 infected
persons (51 females and 38 males), 3 children, an over 20 week pregnant woman and her stillborn child died. The mortality was
of 5 people (5.6%). The age distribution of cases was asymmetrically concentrated between 6 and 15 years (87.5%). In the
N25 year old group, two asymptomatic persons not related to the school were found IgG positive and were considered as chronic
cases or past infection.
3.2. Risk factors
We obtained information on the consumption of artisanal juices in the school from 83 infected persons and 30 non-infected
(Table 2). All positive patients consumed any type of juice at school and this fact was statistically associated with T. cruzi acuteTable 1
Age distribution of population, IgG and IgM antibodies response, prevalence andmortality attributable to oral Chagas disease, Chichiriviche de la Costa, Venezuela, 2009.
Age Population Antibodies response in
examined population
Conﬁrmed n (%) Mortality
IgG IgM
0–5 39 1/38 0 0 1 (stillborn)
6–10 102a 50 52 59 (58.4) 2
11–15 72 18 18 19 (26.4) 1
16–20 48 2 1 2 (4.2) 0
21–25 19 2 2 2 (10.5) 1
N25 161 9b 7 7 (4.3) 0
Total 441 82 80 89 (20.2) 5
a One 7 year-old boy died with fever and myocarditis before performing tests.
b Two asymptomatic adults, chronic cases with IgG+, not belonging to the school.
Table 2
Risk factors in persons with and without oral Chagas disease, Chichiriviche de la Costa, Venezuela, 2009.
Risk factor T. cruzi infection Statistical parameter
Infected
(n = 83)
Uninfected
(n = 30) χ2 p OR 95% CI
Consumption and type of juice Consumption of juice 83 (100%) 23 (76.7%) 20.646 0.000 … …
Guava juice 61 (73.5%) 13 (43.3%) 8.869 0.003 3.626 1.517–8.665
Melon juice 41 (49.4%) 10 (33.3%) 2.296 0.130 1.952 0.816–4.672
Passion fruit juice 44 (53.0%) 10 (33.3%) 3.420 0.064 2.256 0.943–5.402
Tamarind juice 45 (54.2%) 11 (36.7%) 2.715 0.099 2.045 0.866–4.829
Peach or soursop juice 36 (43.4%) 9 (30.0%) 1.645 0.200 1.787 0.731–4.367
Pineapple juice 38 (45.8%) 10 (33.3%) 1.398 0.237 1.689 0.705–4.045
Watermelon juice 35 (42.2%) 8 (26.7%) 2.246 0.134 2.005 0.800–5.027
Orange juice 36 (43.4%) 8 (26.7%) 2.587 0.108 2.106 0.841–5.276
Papaya juice 34 (41.0%) 7 (23.3%) 2.963 0.085 2.280 0.880–5.910
Age Age ≤ 18 years-old 80 (89.9%) 9 (10.1%) 51.942 0.000 9.847 4.792–20.233
Relation with school School-related 88 (98.9%) 1 (1.1%) 56.252 0.000 101.538 13.21–780.76
χ2 of Pearson calculated with one degree of freedom; OR: odds ratio; 95% CI: 95% conﬁdence interval.
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statistically rationed to OChD (p b 0.05); results of OR suggest a direct relation between oral infection by T. cruzi and the habit of
drinking artisanal guava juice and no other type of juice.
Another risk factor evaluated was the relation with school and acute infection by T. cruzi. From 89 patients, 88 were school-
related. The one left was an indigent man who sporadically visited the school. We found statistical signiﬁcance (p = 0.000)
and direct relation between the fact of belonging to the school and the risk to acquire OChD as suggested by OR results
(Table 2). Age ≤ 18 years-old also was a risk factor for OChD in Chichiriviche de la Costa, since from 89 infected, 80 (80.9%)
were under 18 years of age (p = 0.000) (Table 2). We questioned 94 individuals, 44 referred to have observed sometime
triatomines in houses or in the school. Some P. geniculatus were collected by persons of the community.
3.3. Symptomatology
From the 89 patients with OChD, 80 (89.9%) presented any symptomatology. Fever started at the beginning of March 2009, 77
out of 88 patients presented this symptom (Table 3). Results of OR (95% CI) suggest a direct relation between fever and presence
of infection. In patients with OChD, the fever had mean duration of 11.4 days (range 2–23 days), while in a serologic negative
group (n = 22) that declared fever, it lasted 4.3 days (2–10). The t-test demonstrated statistical difference between duration
of fever between infected and non-infected people (p = 0.02). A graphical overview on the timeline of the microepidemic
shows the spatial distribution of diagnosed cases (Fig. 2).
Cardiac symptoms included dyspnea, precordial pain and palpitations; dry cough, odynophagia and dysphonia among respira-
tory symptoms; and abdominal pain, nausea, vomiting and diarrhea into the gastro-intestinal symptoms. The frequency of these
symptoms in the conﬁrmed cases is shown in Table 3. Twenty-ﬁve infected individuals presented edema (Table 3); in 22, the
edema committing the entire face; two (one of 11 year-old and one of 21 year-old) had anasarca and one 34 year-old woman
presented only edema in limbs.
3.4. Cardiac outcomes
Most of the 80 echocardiograms performed resulted with any alteration (98.8%) with varying degrees of pericardial effusion
(82.3%), 14 had left ventricle hypertrophy (15.7%) with or without pericardial effusion (Table 4). There was not statistical signif-
icance (p = 0.980) between altered echocardiogram according to age in patients with acute OChD. Fig. 3 shows facial edema,
thoracic X Ray and echocardiogram of the pregnant women who died in this outbreak.Table 3
Symptomatology in 88 persons with acute oral Chagas disease. Chichiriviche
de la Costa, Venezuela, 2009.
Symptoms n (%)
Fever 77 (87.5%)
Cardiac 23 (26.1%)
Respiratory 7 (8.0%)
Gastro-intestinal 26 (29.5%)
Edema 25 (28.4%)
Adenopathy 5 (5.7%)
Weakness, dizziness, asthenia 10 (11.4%)
Other symptoms 38 (43.2%)
Fig. 2. Timeline of the onset of fever in oral transmitted Chagas disease patients, Chichiriviche de la Costa, Venezuela, 2009.
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(p = 0.374) with continuous age and altered EKG. Hospitalization occurred in 73 patients and they were spread in at least 5
hospitals.
3.5. Laboratory diagnosis
The ﬁrst 20 serum samples were received at the IMT (April 6th, 2009), 4–6 weeks after the onset of symptoms one week later
the samples of the entire population at risk (n = 440) arrived and were searched for IgG and IgM anti-T. cruzi antibodies. All
other tests (IHA, LA, serum IgA, IgG and IgA in saliva, cultures and PCR) were performed on samples from conﬁrmed cases.
T. cruzi parasites were seen in fresh and stained thin blood smears of 14 non-treated hospitalized persons. Fresh preparations
were examined from all the tubes taken for culture (n = 67), but, in the middle of the emergency these results were not record-
ed. Table 5 shows the results of laboratory tests on serum, saliva and blood distributed by age group of conﬁrmed cases indicating
the denominators in each case. No parasitological or serological test diagnosed 100% of those positive. The IHA and the determi-
nation of LA were the tests with highest sensitivity (95.4% and 92.7%, respectively). Sensitivity was 80.9% for both IgM and IgG.
Serum IgA was positive in 73 patients out of 83 diagnosed (87.9%). Instead, both IgG and IgA in saliva resulted with very low
sensitivity (22.9% and 36.4%, respectively).
Blood samples for culture and PCR were taken from the same individuals, but 17 of the PCR were lost. T. cruzi was found in
cultures of 51 patients out of 67 (76.1%) taken from the 88 conﬁrmed cases and parasite DNA was detectable in 40 out of 50
patients examined (80%). Positive cultures and positive PCR agreed on 27 people. Direct or indirect demonstration of the parasite
by these means was possible in 95.5% of the evaluated individuals.
3.6. Molecular characterization
The PCR analysis of the mini-exon gene, domains of the rRNA-24Sα and subunit 18S of the rRNA, revealed that the T. cruzi
DTU in this environment is TcI (Fig. 4a and b). Analysis of the SL-IR gene for haplotype identiﬁcation shows heterogeneity inTable 4
Echographical and electrocardiographical ﬁndings in 89 patients with acute oral Chagas disease, Chichiriviche de la Costa, Venezuela, 2009.
Age
Cardiological tests
Echocardiogram Electrocardiogram
Infected Realized Pericardial effusion HLVa Realized Abnormal
6–10 59 56 44 10 44 16
11–15 19 18 13 4 11 7
16–20 2 1 1 0 1 0
21–25 2 1 1 0 1 0
N25 7 4 4 0 4 2
Total 89 80 65 14 61 25
a Hypertrophy of left ventricle.
Fig. 3. A fatal orally-transmitted Chagas disease case: a pregnant cook lady 24 years old. Noticeable facial edema. X Ray: cardiothoracic relationship N50% without
signs of pulmonary hypertension. Cardiac enlargement due to pericardial effusion. Echosonogram: short axis projection where pericardial effusion and increased
left ventricular wall are evidenced by edema.
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Chic1 is TcIa + TcIb, isolate Chic 4 is TcIa + TcId and isolate from P. geniculatus is TcIb + TcId (Fig. 4b and c). The values of par-
asitic loads of four random samples of T. cruzi infected individuals in this outbreak, are in the range of the 2.4–4.19 Log Par./10 mL
and 1.57–4.67 Log Par./10 mL by the DNAsat and kDNA qPCR methods (clinical sensitivity for acute ChD, 100%) (Fig. 4b).
Table 5
Laboratory tests performed in serum, saliva and blood by age range groups in conﬁrmed cases, Chichiriviche de la Costa, Venezuela, 2009.
Age
Sera Saliva Blood
IgM IgG IgA IHA LA IgG IgA Culture PCR
0–5 0 0 0 0 0 0 0 0 0
6–10a 52/58 50/58 50/56 54/58 45/49 11/50 16/50 33/43 25/32
11–15 18/19 18/19 15/18 19/19 13/13 2/17 6/17 13/16 10/12
16–20 1/2 2/2 2/2 2/2 1/1 0/1 1/1 1/2 0/0
21–25 2/2 2/2 1/1 2/2 0/0 0/0 0/0 2/2 1/2
N25 7/7 7/7 5/6 7/7 5/6 4/6 4/6 2/4 4/4
Total 80/88 79/88 73/83 84/88 64/69 17/74 27/74 51/67 40/50
a One 7 year-old boy died before performing tests; IHA: Indirect hemagglutination; LA: lytic antibodies positives/examined.
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Several biotic and abiotic conditions have favored the urban domiciliation of P. geniculatus (Alarcón de Noya & Noya, 2015).
Some cultural customs, such as the preparation of artisanal juices (Alarcón de Noya et al., 2010) and the consumption of contam-
inated sugar cane and aҫai (Valente et al., 1999), are factors that have contributed to the food contamination by triatomine feces
or whole infected bugs (Alarcón de Noya & Noya, 2015). Based on the progressive increase in the number of cases, our view is
that foodborne transmission will increase and therefore, oral transmission will become the most important route of ChD infection,
more than cutaneous vectorial, congenital and transfusional modes of transmission in this region (Pinto et al., 2008; Alarcón de
Noya & Noya, 2015).
After an outbreak occurred in an urban school in Venezuela, we thought that a fortuity episode had occurred and that we
would never again see something like Chacao school microepidemic (Alarcón de Noya et al., 2010). Even though the screening
was performed on the population present at the time of sampling, the conﬁrmed acute cases had occurred in members of the
school (students, teachers, cooks, administrative staff and an indigent individual). During the microepidemic, prolonged fever,
being under 18, attending the school and drinking guava juice at school were statistically signiﬁcant risk factors. The association
between those infected and guava juice intake recalls the testimony of the preparation of juice exactly as it occurred in theFig. 4. Molecular characterization of Trypanosoma cruzi isolates of the outbreak of Chagas disease by oral route occurred in Chichiriviche de la Costa, Venezuela.
a) Schematic representation of the ampliﬁed products expected for each of the Trypanosoma cruzi DTUs. b) Description of molecular data of the different Chagas
disease patients included in this study, and their parasitic loads measured by SatDNA and kDNA qPCR assays. c) Sequence of the SL-IR microsatellite motif and
characterization of haplotypes by each isolate of Trypanosoma cruzi from vector and patients. (+): CQ strain (DTU I); (−): CL-Brener strain (DTU VI); ND: Unde-
termined; NQ: Unquantiﬁable; nt: nucleotides. SatDNA qPCR limit of quantiﬁcation (1.53 par.eq./mL); kDNA qPCR limit of quantiﬁcation (0.90 par.eq./mL).
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triatomines could fall into the guava preparation and contaminate it. For a second time, a contaminated juice was the vehicle of
trypomastigotes causing the infection of many children. In endemic countries, widespread consumption of handmade juices in
schools should be banned, and replaced by pasteurized ones.
Despite the fact that symptoms started simultaneously, it was not possible to speculate about the infection date or week since
guava juice consumption was frequent. High prolonged fever occurred in 87.5% of the infected individuals and it was the predom-
inant symptom. Other symptoms, such as edema, weakness, pre-cordial and abdominal pain were less frequent (26–29. 5%). By
the time that the ChD outbreak occurred, there was dengue (short-lasting fever) in the region, confusing the initial diagnosis.
In Chichiriviche de la Costa, symptomatology and mortality (5.6%) were much higher than in Chacao, (Alarcón de Noya et al.,
2010) possibly because the approach occurred later. When sample processing initiated, people already had symptoms for four
to six weeks. This time was critical allowing the deaths of four persons and one stillborn. The only autopsied case demonstrated
a disseminated T. cruzi infection in all examined organs in the young pregnant cook (Suárez et al., 2010). Moreover, 73 infected
persons were hospitalized in different medical facilities, making the appropriate treatment difﬁcult and sometimes worsening the
clinical picture with the use of steroids, masking the presence of an active systemic infection by T. cruzi. Pericardial effusion was
present in 81.3% of the infected individuals and this demonstrable sign was not accompanied by related symptoms in the same
proportion. While the largest frequency occurred in the 6 to 10-age group, probably children most likely did not complain of
dyspnea or precordial pain or adults might not have paid much attention to them. Of 61 EKGs available from infected individuals
by the time they started treatment, 41% were abnormal, showing mainly alteration of the repolarization. In the present cohort,
pericardial effusion seems to be more frequent than the arrhythmias described in other outbreaks (Shikanai-Yasuda & Carvalho,
2012; Bastos et al., 2010; Marques et al., 2013), probably because the echosonographic studies were systematically performed in
all infected individuals since the beginning and we did not examine their early EKGs.
The clinical diagnosis of the acute phase of the ChD is not simple because the symptoms are nonspeciﬁc and in the cases of
children, the voicing of chest pain, dizziness and weakness, is ambiguous. Once the physician has a suspicion and conﬁrms the
ﬁrst cases, as happened in this occurrence, a panel of tests must be performed for the unequivocal veriﬁcation of acute cases.
In anticipation of the presence of a large outbreak by an increase in number of symptomatic individuals, the most efﬁcient
way to address a community is to perform simultaneous determination of speciﬁc IgG and IgM. Once the infected population is
identiﬁed, conﬁrmation of cases is necessary. This conﬁrmation was achieved with IHA and LA, which proved to be more sensitive
techniques in this cohort. The antibody kinetics of IgM, IgG, IgA and lytic antibodies depends upon the moment in which the pop-
ulation is studied (Antas et al., 1999). Noteworthy, no individual technique was able to detect 100% of the conﬁrmed cases. These
results are similar to those found in the ﬁrst school's microepidemic (Alarcón de Noya et al., 2012). Serologic studies can be quick-
ly performed and the combination of two or three techniques is enough for the detection of 100% of cases (WHO, 2002). During
the acute phase in oral outbreaks, attention should be paid to symptomatic people since initially there may be false negatives.
Consequently, febrile patients linked to the outbreak with negative tests or only one serological positive result should be treated
(Alarcón de Noya et al., 2010; Alarcón de Noya et al., 2012).
As said above, the incubation period is unknown and all samples were taken at least four weeks after the onset of symptoms.
By this time, IgA had probably decreased in blood and saliva. While the determination of serum IgA fared well with a sensitivity of
87.9%, saliva tests were not good. Sampling saliva can be an alternative for people with reluctance to give a blood sample. In
chronic ChD patients, Pinho et al. (Pinho et al., 1999) had a sensitivity and speciﬁcity of IgG in saliva of 90.4% and 95%, respec-
tively. This was not the case in acute OChD patients whose IgG and IgA sensitivities in saliva were very low.
Although the present results are not comparable to other less numerous outbreaks (Shikanai-Yasuda & Carvalho, 2012; Alarcón
de Noya et al., 2015; Rueda et al., 2014; Díaz et al., 2015; Añez et al., 2013), it certainly represents one of the occurrences in which
it was possible to demonstrate the presence of the parasite in almost all patients, thus relating in this way the symptoms to the
causative agent T. cruzi. The direct or indirect detection of the parasite in this outbreak was higher compared to that in the Chacao
microepidemic, since in Chichiriviche combined culture and PCR detected T. cruzi in 95.5% of the conﬁrmed cases.
The difﬁculty of laboratory diagnosis is based on: a. It is difﬁcult for a single technique to diagnose 100% of cases; b. More than
one blood sample should be taken on more than one occasion; c. Hospitals are neither prepared to diagnose OChD nor to offer the
determination of IgM antibodies; d. Reference laboratories may be distant from the outbreak location delaying the arrival of
samples and therefore the diagnosis. However, the direct fresh visualization of the parasite and the microhematocrit are rapid
tests that can be done at any medical level with good sensitivity in the acute phase (Freilij et al., 1983).
The intensity and severity of the acute phase should inﬂuence the course of the infection and the establishment of myocardial
injury (Andrade et al., 2014). Alarcón de Noya et al. (Alarcón de Noya et al., 2011) warned about the evolution of patients in the
two Venezuelan school microepidemics in which, after two and three years post-treatment, about 70% of patients continued to be
LA- and PCR-positive even though the treatment had been supervised to ensure appropriate dosages and duration and that it was
administered to children in the acute phase, when it is considered to be more effective (Viotti & Vigliano, 2015). Certainly, the
longer the patients take to heal, the greater the damage that parasites can generate. All suspected and conﬁrmed cases received
benznidazol 7 mg/kg for 60 days.
As expected, parasitic loads in these acute ChD samples were approximately twice as high for both molecular markers than in
chronic cases (Ramírez et al., 2015). The two samples with the highest parasitic loads belonged to patient Chic5 and patient Chic6,
infected with TcI (haplotype non-determinate). However, in one sample (Chic1), the parasitic load could not be quantiﬁed by
satDNA qPCR method. This can be explained because the analytical sensitivity is more uniform among the different T. cruzi
DTUs for kDNA qPCR than for SatDNA qPCR, indicating lower gene dosage in their genomes (Duffy et al., 2009; Lewis et al., 2009).
197B. Alarcón de Noya et al. / Parasite Epidemiology and Control 1 (2016) 188–198The presence of TcIb is very important because this is the second report where this haplotype, originally described by Herrera
et al. (Herrera et al., 2007), is linked with wild and peridomestic cycles and vectors of the genus Triatoma and Rhodnius and wild
vectors such as Panstrongylus (Falla et al., 2009). Also, this is the ﬁrst evidence of a mixture of haplotypes in a sylvatic vector, sug-
gesting repeated reinfection (Muñoz-Calderón et al., 2013).
For those T. cruzi isolates from orally-infected individuals and assuming all patients were infected from a common source,
T. cruzi exhibited TcI haplotype heterogeneity, suggesting that wild vectors such as P. geniculatus are able to accommodate differ-
ent TcI haplotypes naturally. On the other hand, Diaz et al. (Díaz et al., 2015) analyzing parasite DTU from 6 Colombian outbreaks
found that DTUs are not strictly correlated with clinical forms of the disease. In our results, the ﬁnding of at least two TcI haplo-
types in persons with severe forms of the disease is motive of histopathogenicity studies of the TcI haplotypes alone or combined.
In a small town of no more than 500 inhabitants, the massive infection of children will impact the community in a few years.
It seems that population is not getting cured as expected, probably leaving those who are evolving to chronic ChD with higher
cardiac morbidity than those with the natural course of vectorial infection. As a touristic place where submarine activity is a
mode of life, lower cardiorespiratory capacity is a serious limitation. Girls will soon start to be pregnant with the possibility of
congenital transmission and blood transfusions will be very limited among relatives under emergency situations.
5. Short conclusion
In Chichiriviche de la Costa, Venezuela, a large outbreak of oral transmitted ChD occurred in a rural school in 2009 affecting 89
persons with 5 deaths. The evaluation of risk factors indicated that the ingestion of artisanal guava juice, distributed at school, was
the vehicle of T. cruzi. Foodborne transmission allowed the intake of a large inoculum, reﬂected by the severity of cases, a high
parasitic load in patients, the demonstration of the causative agent in the majority of them, and the systemic invasion of
T. cruzi in an autopsied case. To prevent these outcomes and knowing that no individual parasitological, serological or molecular
technique can diagnose the 100% of acute cases, a set of tests must be timely applied to the population at risk to prevent morbid-
ity and mortality. Chagas disease as a foodborne entity deserves special attention by health authorities because it will not diminish
left alone according to the ecological changes in the endemic areas.
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